administr
recombin
felin
interferonv
rfeifn
propos
prophylaxi
canin
felin
parvovirosi
present
studi
influenc
administr
rfeifn
blood
marker
inflamm
aglobulin
glycoprotein
immun
system
activ
gglobulin
igg
igm
specif
antifelin
parvoviru
igg
igm
evalu
catteri
develop
outbreak
felin
panleukopenia
due
felin
parvoviru
fpv
infect
day
initi
administr
rfeifn
kitten
n
inject
rfeifn
mukg
subcutaneoulsi
day
day
blood
paramet
compar
untreat
cat
cat
surviv
outbreak
vaccin
resampl
month
last
rfeifn
administr
time
emerg
clinic
sign
surviv
rate
significantli
differ
two
group
control
treat
cat
surviv
infect
high
level
gglobulin
totaland
antifpv
specif
igg
like
due
passiv
transfer
matern
immun
compar
control
treat
kitten
lower
level
globulin
higher
mean
valu
gglobulin
immunoglobulin
data
sampl
collect
vaccin
reveal
higher
level
gglobulin
totaland
antifpv
specif
igg
treat
kitten
compar
control
suggest
rfeifn
stimul
antibodi
product
base
result
rfeifn
administ
queen
increas
passiv
matern
immun
kitten
introduct
potenti
contamin
environ
p
vs
ci
p
vs
cii
vs
ti
evalu
inflamm
immun
cat
spontan
parvoviru
infect
consequ
recombin
felin
interferonv
administr
interferon
famili
includ
cytokin
nonspecif
antivir
antiprolif
antiinflammatori
immunomodulatori
activ
specif
type
interferon
ifn
includ
ifna
ifnb
e
ifnv
wonderl
et
al
type
ifn
produc
virusinfect
cell
interact
specif
receptor
adjac
cell
induc
transcrib
gene
code
antivir
protein
consequ
viral
replic
viral
protein
synthesi
decreas
ueda
et
al
uchino
tilg
stark
et
al
wonderl
et
al
type
ii
interferon
includ
ifng
wonderl
et
al
produc
tlymphocyt
nk
cell
ifng
preval
immunomodulatori
activ
character
activ
wwwelseviercomlocatevetimm
veterinari
immunolog
immunopatholog
macrophag
tlymphocyt
nk
cell
lesser
extent
b
cell
mond
et
al
bohem
et
al
sever
viru
type
demonstr
modul
ifn
product
uchino
stark
et
al
moreov
administr
exogen
ifn
popul
high
preval
viral
diseas
earli
phase
viral
infect
inhibit
viral
replic
thu
administr
ifn
may
demonstr
prophylact
effect
may
prevent
worsen
certain
viral
diseas
truyen
et
al
administr
exogen
human
ifn
induc
sever
side
effect
cat
exogen
antigen
induc
product
neutral
antibodi
inhibit
therapeut
effect
activ
principl
zeidner
et
al
administr
speciesspecif
felin
ifn
abl
bypass
problem
truyen
et
al
recombin
felin
ifnv
rfeifn
homolog
human
ifn
ueda
et
al
antivir
pharmacokinet
pharmacolog
properti
similar
human
ifnv
ueda
et
al
b
vitro
rfeifn
proven
antivir
effect
sever
virus
includ
parvoviru
herpesviru
caliciviru
coronaviru
rotaviru
mochizuki
et
al
truyen
et
al
vivo
rfeifn
mainli
use
dog
experiment
spontan
parvovir
infect
consequ
clinic
improv
normal
cbc
result
reduct
mortal
rate
ishiwata
et
al
minagawa
et
al
martin
et
al
dog
rfeifn
also
success
use
associ
vaccin
prevent
outbreak
canin
parvovirosi
uchino
efficaci
rfeifn
cat
felin
infecti
periton
infect
felin
immunodefici
viru
felin
leukaemia
viru
felin
caliciviru
also
report
uchino
mihaljev
de
mari
et
al
ishida
et
al
howev
data
effect
rfeifn
case
spontan
felin
panleukopenia
fp
caus
felin
parvoviru
fpv
avail
administr
rfeifn
kitten
fp
seem
influenc
cours
diseas
person
observ
nevertheless
case
rfeifn
would
modul
inflammatori
immun
respons
administr
rfeifn
may
integr
convent
therapi
may
consid
prophylact
plan
fp
catteri
aim
current
studi
thu
investig
possibl
influenc
rfeifn
administr
inflammatori
immun
respons
kitten
live
rescu
shelter
character
high
preval
fpv
infect
treat
occurr
fp
outbreak
serum
sampl
collect
cat
live
rescu
shelter
host
approxim
adult
cat
kitten
per
year
shelter
chosen
sinc
record
recur
earli
summer
sever
outbreak
fp
kitten
shelter
kitten
age
rang
day
includ
studi
randomli
divid
two
group
control
receiv
treatment
treat
receiv
mukg
rfeifn
virbagen
omega
virbac
carro
cedex
franc
subcutaneoulsi
day
day
suggest
cat
affect
viral
disord
ishida
et
al
approxim
week
prior
expect
time
fp
outbreak
refer
veterinarian
start
administr
rfeifn
treat
group
rfeifn
administr
day
cat
receiv
complet
daili
physic
examin
day
abnorm
clinic
find
death
record
especi
case
clinic
sign
consist
felin
panleukopenia
case
clinic
sign
support
therapi
chosen
basi
preval
clinic
sign
administ
control
treat
kitten
blood
sampl
collect
control
treat
cat
irrespect
presenc
clinic
sign
period
rang
day
two
group
cat
among
still
aliv
symptomat
outbreak
randomli
select
vaccin
felin
panleukopenia
calicivirosi
herpesvirosi
feligen
crp
virbac
day
rfeifn
administr
addit
blood
sampl
collect
day
vaccin
control
vaccin
treat
cat
blood
taken
jugular
vein
put
plain
tube
blood
sampl
immedi
submit
laboratori
process
blind
manner
serum
obtain
centrifug
separ
store
analysi
complet
postmortem
examin
perform
cat
die
clinic
sign
consist
felin
parvovirosi
control
group
treat
group
total
protein
measur
serum
sampl
discret
analys
eosbravo
hospitex
firenz
itali
use
biuret
method
hospitex
firenz
itali
serum
protein
electrophoresi
perform
use
semimicro
method
cellulos
polyacet
strip
seac
firenz
itali
barbiton
trisbuff
helena
lab
italia
spa
assago
mi
itali
strip
run
min
v
stain
min
red
ponceau
g
ml
trichloroacet
acid
destain
acet
acid
put
diaphanis
solut
helena
lab
italia
spa
gel
scan
densitomet
biotecnica
instrument
roma
itali
radial
immunodiffus
rid
kit
use
measur
igg
igm
vetrid
bethyl
laboratori
inc
montgomeri
usa
agp
tridelta
ltd
dublin
ireland
accord
manufactur
instruct
concentr
specif
antiparvovir
serum
antibodi
evalu
use
commerci
avail
multiwellslid
coat
crandel
felin
kidney
cell
infect
fpv
strain
vmrd
inc
pullman
wa
usa
briefli
ml
serum
sampl
dilut
pb
put
well
incub
min
wash
pb
antifelin
igg
nordic
immunolog
laboratori
titburg
netherland
ad
well
incub
well
min
wash
pb
slide
coverslip
glycerin
examin
fluoresc
microscop
posit
well
consid
fluoresc
cell
posit
sera
dilut
twofold
basi
neg
result
obtain
antibodi
titr
correspond
last
dilut
provid
posit
result
step
repeat
differ
slide
use
antifelin
igm
antibodi
vmrd
inc
secondari
antibodi
instead
antifelin
igg
posit
fpl
posit
control
vmrd
inc
neg
control
pb
alon
includ
session
test
statist
analysi
perform
util
softwar
statistica
statsoft
inc
tulsa
ok
usa
surviv
curv
design
use
kaplanmey
method
differ
group
calcul
use
gean
wilcoxon
test
data
control
treat
anim
compar
student
ttest
independ
sampl
normal
test
show
data
nonnorm
distribut
correspond
mannwithney
nonparametr
utest
data
repeat
sampl
anim
compar
student
ttest
depend
sampl
correspond
wilcoxon
nonparametr
test
outbreak
felin
panleukopenia
occur
catteri
week
follow
rfeifn
administr
day
begin
studi
period
clinic
sign
consist
fp
vomit
diarrhoea
anorexia
sudden
death
hyperacut
gastroenter
episod
record
control
cat
treat
cat
among
symptomat
cat
control
treat
kitten
die
surviv
rate
among
control
among
treat
anim
signific
differ
two
group
record
term
time
appear
clinic
sign
surviv
rate
fig
necropsi
confirm
diagnosi
acut
felin
parvovirosi
nine
cat
examin
cat
necrot
hemorrag
enter
involv
small
intestin
jejunum
andor
ileum
histolog
character
necrosi
crypt
epithelium
variabl
sever
crypt
often
dilat
contain
abund
lumin
cellular
debri
area
show
flatten
epitheli
line
crypt
epitheli
cell
dysplasia
detect
addit
find
sever
lymphoid
deplet
lymph
node
cortex
splenic
white
pulp
bone
marrow
also
moder
sever
hypocellular
sever
lesion
lymphoid
organ
bone
marrow
similar
control
treat
cat
individu
data
obtain
control
treat
cat
outbreak
fig
evidenc
cat
surviv
outbreak
higher
level
gglobulin
igg
specif
antifpv
igg
compar
die
treat
cat
significantli
lower
level
globulin
agp
compar
control
tabl
blood
sampl
collect
day
treat
cat
significantli
higher
level
gglobulin
igg
antifpv
specif
igg
tabl
paramet
significantli
higher
treat
cat
sampl
day
rfeifn
administr
compar
treat
cat
sampl
outbreak
tabl
aim
studi
evalu
possibl
influenc
administr
recombin
felin
ifnv
serum
marker
inflamm
immun
kitten
live
rescu
shelter
character
high
preval
felin
parvoviru
infect
knowledg
first
field
studi
evalu
influenc
rfeifn
field
studi
felin
rescu
shelter
type
approach
advantag
correspond
routin
daili
practic
howev
major
pitfal
consequ
lack
standard
matter
fact
field
studi
fig
distribut
result
regard
serum
protein
electrophoresi
agp
total
fpv
specif
igg
igm
record
outbreak
felin
panleukopenia
control
c
cat
treat
rfeifn
white
dot
cat
surviv
outbreak
black
dot
cat
die
outbreak
possibl
defin
time
intercur
initi
infect
ifnadministr
addit
cat
complet
work
sinc
die
night
weekend
imped
collect
fresh
blood
tissu
also
instanc
sampl
hemolyt
exclud
studi
although
day
fp
outbreak
could
calcul
precis
rfeifn
administr
initi
base
mean
outbreak
start
date
record
past
year
expect
outbreak
occur
week
begin
administr
specif
first
clinic
sign
death
record
day
kitten
treat
group
still
receiv
rfeifn
dose
rfeifn
administ
cat
viral
diseas
ishida
et
al
protocol
close
resembl
one
appli
canin
speci
character
rfeifn
administr
follow
vaccin
either
introduct
anim
contamin
environ
immedi
appear
clinic
sign
consist
diseas
uchino
martin
et
al
truyen
et
al
unfortun
possibl
perform
necropsi
dead
cat
due
poor
condit
carcass
investig
presenc
felin
panleukopenia
virus
faec
survivor
perform
leukocyt
count
aliv
symptomat
anim
incomplet
collect
materi
consequ
high
temperatur
long
laps
time
death
collect
sampl
allow
demonstr
fpv
cat
includ
nevertheless
clinic
sign
record
consist
acut
form
fp
necropsi
histolog
confirm
diagnosi
nine
cat
could
examin
find
coupl
knowledg
regard
fpv
ecolog
epidemiolog
clinic
present
togeth
find
specif
antifpv
igm
produc
acut
phase
infect
allow
us
conclud
fp
present
catteri
like
affect
cat
contrarili
report
dog
studi
administr
rfeifn
influenc
develop
clinic
sign
surviv
rate
outbreak
minagawa
et
al
martin
et
al
de
mari
et
al
nevertheless
analysi
serum
level
indirect
marker
inflammationimmun
demonstr
rfeifn
influenc
develop
inflamm
immun
respons
fpv
although
number
anim
includ
studi
compar
greater
previou
laboratori
experi
martin
et
al
de
mari
et
al
total
number
cat
per
group
low
detect
statist
signific
differ
cat
without
clinic
sign
moreov
type
statist
error
eg
overestim
statist
signific
might
affect
data
analysi
due
multipl
differ
analys
biochem
data
nevertheless
individu
data
collect
outbreak
evidenc
high
level
totaland
antifpv
specif
igg
cat
group
nonsymptomat
sampl
especi
surviv
infect
data
support
hypothesi
pollock
carmichael
matern
passiv
igg
transfer
protect
parvoviru
allow
kitten
mount
moder
system
inflammatori
respons
seem
protect
worsen
death
contrari
symptomat
cat
includ
one
kitten
vaccin
day
sampl
major
electrophoret
chang
data
shown
like
due
hyperacut
cours
diseas
agp
level
symptomat
nonsymptomat
control
cat
within
rang
report
control
includ
previou
studi
kajikawa
et
al
lack
inflammatori
chang
symptomat
control
may
consequ
hyperacut
cours
diseas
although
experiment
induc
inflamm
agp
increas
within
h
kajikawa
et
al
cat
includ
present
studi
die
within
hour
appear
clinic
sign
case
found
preagon
agon
state
thu
probabl
possibl
increas
circul
agp
concentr
agp
aglobulin
electrophoret
fraction
agp
acut
phase
protein
migrat
treat
cat
lower
control
suggest
rfeifn
treatment
depress
call
acut
phase
reaction
like
trough
possibl
influenc
cytokin
network
respons
system
respons
inflamm
contrari
rfeifn
administr
induc
signific
chang
gglobulin
total
fpv
specif
antibodi
class
howev
consid
surpris
sinc
interv
last
treatment
blood
sampl
low
day
evid
chang
paramet
nevertheless
analysi
individu
data
indic
cat
treat
group
higher
level
igm
higher
antifpv
igm
titr
compar
untreat
cat
thu
suggest
spite
short
delay
mention
cat
treat
group
mount
earli
igmmedi
immunerespons
fpv
mechan
rfeifn
exert
effect
infer
studi
howev
hypothesi
rfeifn
stimul
immun
system
respons
confirm
result
obtain
day
treat
cat
intens
respons
vaccin
trial
higher
level
gglobulin
total
fpv
specif
igg
compar
control
cat
result
present
studi
suggest
spontan
felin
panleukopenia
rfeifn
antivir
effect
typic
type
interferon
contrari
report
vitro
dog
mochizuki
et
al
truyen
et
al
ishiwata
et
al
minagawa
et
al
martin
et
al
de
mari
et
al
treat
control
kitten
viral
spread
caus
similar
morbid
mortal
rate
howev
due
limit
field
studi
possibl
conclud
rfeifn
immunotherapeut
role
fpv
contrari
treat
anim
seem
reactiv
immun
system
demonstr
vaccin
trial
reduc
acut
inflammatori
respons
power
immunomodulatori
activ
suggest
rfeifn
treatment
kitten
week
prior
introduct
high
risk
environ
follow
vaccin
preced
treatment
queen
improv
transfer
passiv
matern
immun
may
provid
kitten
good
level
igg
expos
viru
immunomodulatori
effect
taken
consider
design
prophylact
scheme
prevent
felin
parvovir
outbreak
